Cargando…
Expression and function of myelin expression factor 2 in hepatocellular carcinoma
INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most common malignant tumours in the world and has a high mortality rate. However, the pathogenesis of HCC remains unclear. This study aimed to investigate the potential biomarkers of HCC. METHODS: ONCOMINE, HCCDB and THE HUMAN PROTEIN ATLAS...
Autores principales: | Zhang, Peng, Zhao, Jiang-Hua, Chen, Lin, Bian, Zhao-Lian, Ju, Lin-Ling, Wang, Hui-Xuan, Cai, Wei-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854206/ https://www.ncbi.nlm.nih.gov/pubmed/36658471 http://dx.doi.org/10.1186/s12876-023-02644-3 |
Ejemplares similares
-
DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases
por: Zhang, Peng, et al.
Publicado: (2023) -
Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Chen, Jiang, et al.
Publicado: (2014) -
Effect of NDC80 in human hepatocellular carcinoma
por: Ju, Lin-Ling, et al.
Publicado: (2017) -
Expression Characteristics of KAI1 and Vascular Endothelial Growth Factor and Their Diagnostic Value for Hepatocellular Carcinoma
por: Zhang, Wu, et al.
Publicado: (2014) -
Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)